Torres Denice
SEC insider (Form 3/4/5 filer). CIK 0001820278. Director at Celldex Therapeutics, Inc. (CLDX) and 3 other issuers. 11 reported Form 4/5 transactions since Sep 2024; latest on Jun 25, 2026. Located in ALISO VIEJO, CA.
Companies Torres Denice has filed insider reports for
- Celldex Therapeutics, Inc. (CLDX): Director
- GLAUKOS Corp (GKOS): Director
- Seaport Therapeutics, Inc. (SPTX): Director
- 2seventy bio, Inc. (TSVT): Director
Torres Denice
CIK: 0001820278
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jun 25, 2026CLDX
Celldex Therapeutics, Inc.
AwardDirectNon-Qualified Stock Option (right to buy)
26K shares- - May 28, 2026GKOS
GLAUKOS Corp
AwardDirectStock Option (Right to Buy)
3K shares- - May 28, 2026GKOS
GLAUKOS Corp
AwardDirect1.9K shares- - May 4, 2026SPTX
Seaport Therapeutics, Inc.
ConversionIndirect13.4K shares- - Apr 30, 2026SPTX
Seaport Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
12.3K shares- - Jan 2, 2026GKOS
GLAUKOS Corp
AwardDirect623 shares- - Jun 5, 2025CLDX
Celldex Therapeutics, Inc.
AwardDirectNon-Qualified Stock Option (right to buy)
33K shares- - May 29, 2025GKOS
GLAUKOS Corp
AwardDirect2.1K shares- - May 13, 2025TSVT
2seventy bio, Inc.
Tender OfferDirect19.5K shares- - May 13, 2025TSVT
2seventy bio, Inc.
DispositionDirect12.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 25, 2026 |  CLDX Celldex Therapeutics, Inc. | Award Non-Qualified Stock Option (right to buy) | 26,000 | - | - | Direct |
| May 28, 2026 |  GKOS GLAUKOS Corp | Award Stock Option (Right to Buy) | 2,987 | - | - | Direct |
| May 28, 2026 | GKOS GLAUKOS Corp | Award | 1,878 | - | $0 | Direct |
| May 4, 2026 |  SPTX Seaport Therapeutics, Inc. | Conversion | 13,406 | - | $0 | Indirect |
| Apr 30, 2026 | SPTX Seaport Therapeutics, Inc. | Award Stock Option (Right to Buy) | 12,258 | - | - | Direct |
| Jan 2, 2026 | GKOS GLAUKOS Corp | Award | 623 | - | $0 | Direct |
| Jun 5, 2025 | CLDX Celldex Therapeutics, Inc. | Award Non-Qualified Stock Option (right to buy) | 33,000 | - | - | Direct |
| May 29, 2025 | GKOS GLAUKOS Corp | Award | 2,108 | - | - | Direct |
| May 13, 2025 |  TSVT 2seventy bio, Inc. | Tender Offer | 19,510 | - | - | Direct |
| May 13, 2025 | TSVT 2seventy bio, Inc. | Disposition | 12,050 | - | - | Direct |
1-10 of 11 transactions